Skip to content
Screener

Total Current Liabilities at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$15.07B+18.5%
Danaher logo
DanaherDHR
$8.11B+19.3%
Repligen logo
RepligenRGEN
$132.66M+7.8%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$917M+81.0%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
$72.74M-24.8%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$1.13B+5.0%

Other financials

Income statement

See full
Revenue$51.4M+8.5%
Gross profit$20.7M+166%
Operating income-$15.1M+77.2%
Net income-$12.4M+68.6%
EPS (diluted)-$0.08+70.4%

Balance sheet

See full
Cash & equivalents$70.6M-73.8%
Total debt$176.7M-52.4%
Total equity$204.6M-23.0%
Total assets$603.7M-32.7%

Cash flow

See full
Operating cash flow$4.0M+139%
CapEx$370.0K-87.1%
Free cash flow$3.6M+128%

Valuation

See full
Market cap$918.96M+210%
Enterprise value$1.03B+158%
P/S4.4×+3.1×

Profitability

See full
Gross margin34.9%+4.4pp
Operating margin-56.1%-21.3pp
Net margin-37.1%-13.6pp
FCF margin-17.2%

Returns & leverage

See full
Return on equity-32.9%-9.4pp
Debt / equity0.9×-0.5×
Current ratio4.1×-1.1×

Where this comes from

Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.

The source filing: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 4:03 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001823239-26-000059
Line itemJune 30, 2026December 31, 2025
Accounts payable$7,125$2,910
Accrued expenses and other current liabilities30,16936,567
Current portion of long-term debt1,1255,440
Total current liabilities38,41944,917
Long-term debt, less current portion145,980286,331
Finance lease liabilities, less current portion29,59130,141
Other long-term liabilities34,16836,477
Total liabilities248,158397,866

Item 1. Financial Statements

FAQ

What is Maravai LifeSciences Holdings, Inc.'s total current liabilities?
Maravai LifeSciences Holdings, Inc. (MRVI) reported total current liabilities of $38.42M in Q2 2026.
How has Maravai LifeSciences Holdings, Inc.'s total current liabilities changed year-over-year?
Maravai LifeSciences Holdings, Inc.'s total current liabilities decreased by 44.9% year-over-year, from $69.68M to $38.42M.
What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s total current liabilities?
Over 5 years (2020 to 2025), Maravai LifeSciences Holdings, Inc.'s total current liabilities has grown at a -19.2% compound annual growth rate (CAGR), from $130.78M to $44.92M.
What does total current liabilities mean?
The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.

Ask your AI about Maravai LifeSciences Holdings, Inc.'s total current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude